SEC 13F Intelligence

Dsc Advisors, L.P. / TEVA

Dsc Advisors, L.P.’s Teva Pharmaceutical Inds Ltd Position

Does Dsc Advisors, L.P. own Teva Pharmaceutical Inds Ltd (TEVA)? Not currently — the last reported position was 292.5K shares worth $3M in Q3 2023; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$3M
Q3 2023
Shares
292.5K
% of Portfolio
+3.83%
Quarters Held
4
position exited

Position History TEVA

Reported value by quarter
Q3 ’22: $726,000Q3 ’22Q1 ’23: $2MQ1 ’23Q2 ’23: $2MQ2 ’23Q3 ’23: $3MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2023292.5K$3M+3.83%
Q2 2023310.0K$2M+3.50%
Q1 2023180.0K$2M+1.39%
Q3 202290.0K$726,000+0.75%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dsc Advisors, L.P.’s full portfolio or all institutional holders of TEVA.